{ "article": { "LEGIARTI000026592257": { "META": { "META_SPEC": { "META_ARTICLE": { "NUM": "R5121-209", "ETAT": "MODIFIE", "TYPE": "AUTONOME", "DATE_FIN": "2022-02-19", "DATE_DEBUT": "2012-11-09" } }, "META_COMMUN": { "ID": "LEGIARTI000026592257", "URL": "article/LEGI/ARTI/00/00/26/59/22/LEGIARTI000026592257.xml", "NATURE": "Article", "ORIGINE": "LEGI" } }, "LIENS": { "LIEN": [ { "@id": "LEGIARTI000026589556", "@num": "3", "#text": "Décret n°2012-1236\n du 6 novembre 2012 - art. 3", "@sens": "cible", "@cidtexte": "JORFTEXT000026588856", "@nortexte": "AFSP1226229D", "@numtexte": "2012-1236", "@typelien": "MODIFIE", "@naturetexte": "DECRET", "@datesignatexte": "2012-11-06" }, { "@id": "LEGIARTI000006689870", "@num": "L5121-1", "#text": "Code de la santé publique - art. L5121-1", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CITATION", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590222", "@num": "R5121-217", "#text": "Code de la santé publique - art. R5121-217 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CONCORDE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" } ] }, "CONTEXTE": { "TEXTE": { "TM": { "TM": { "TM": { "TM": { "TM": { "TM": { "TITRE_TM": [ { "@id": "LEGISCTA000019498038", "@fin": "2012-11-09", "#text": "Section 17 : Modalités d'application aux hôpitaux des armées et au centre de transfusion sanguine des armées.", "@debut": "2008-09-19" }, { "@id": "LEGISCTA000026592262", "@fin": "2999-01-01", "#text": "Section 17 : Conditions d'autorisation des médicaments de thérapie innovante préparés ponctuellement", "@debut": "2012-11-09" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006178649", "@fin": "2999-01-01", "#text": "Chapitre Ier : Dispositions générales", "@debut": "2004-08-08" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006161012", "@fin": "2999-01-01", "#text": "Titre II : Médicaments à usage humain", "@debut": "2004-08-08" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006145489", "@fin": "2999-01-01", "#text": "Livre Ier : Produits pharmaceutiques", "@debut": "2004-07-29" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006132399", "@fin": "2999-01-01", "#text": "Cinquième partie : Produits de santé", "@debut": "2004-07-29" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006112927", "@fin": "2999-01-01", "#text": "Partie réglementaire", "@debut": "2000-12-23" } ] }, "@cid": "LEGITEXT000006072665", "@nature": "CODE", "TITRE_TXT": [ { "@fin": "2999-01-01", "#text": "Code de la santé publique", "@debut": "1953-10-07", "@id_txt": "LEGITEXT000006072665", "@c_titre_court": "Code de la santé publique" } ], "@date_publi": "2999-01-01", "@date_signature": "2999-01-01" } }, "VERSIONS": { "VERSION": [ { "@etat": "TRANSFERE", "LIEN_ART": { "@id": "LEGIARTI000019498036", "@fin": "2012-11-09", "@num": "R5121-209", "@etat": "TRANSFERE", "@debut": "2008-09-19", "@origine": "LEGI" } }, { "@etat": "MODIFIE", "LIEN_ART": { "@id": "LEGIARTI000026592257", "@fin": "2022-02-19", "@num": "R5121-209", "@etat": "MODIFIE", "@debut": "2012-11-09", "@origine": "LEGI" } }, { "@etat": "VIGUEUR", "LIEN_ART": { "@id": "LEGIARTI000045187742", "@fin": "2999-01-01", "@num": "R5121-209", "@etat": "VIGUEUR", "@debut": "2022-02-19", "@origine": "LEGI" } } ] }, "BLOC_TEXTUEL": { "CONTENU": "

Pour l'application de la présente section, on entend par médicaments de thérapie innovante préparés ponctuellement les médicaments de thérapie innovante mentionnés au 17° de l'article L. 5121-1.\n

" } }, "LEGIARTI000026589556": { "META": { "META_SPEC": { "META_ARTICLE": { "NUM": "3", "TYPE": "ENTIEREMENT_MODIF", "DATE_FIN": "2999-01-01", "DATE_DEBUT": "2999-01-01" } }, "META_COMMUN": { "ID": "LEGIARTI000026589556", "URL": "article/LEGI/ARTI/00/00/26/58/95/LEGIARTI000026589556.xml", "NATURE": "Article", "ORIGINE": "LEGI" } }, "LIENS": { "LIEN": [ { "@id": "LEGISCTA000026592262", "#text": "Code de la santé publique - Section 17 : Conditions d'autorisation des méd... (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGISCTA000026590174", "#text": "Code de la santé publique - Section 18 : Modalités d'application aux hôpit... (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026592257", "@num": "R5121-209", "#text": "Code de la santé publique - art. R5121-209 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "MODIFIE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000019498036", "@num": "R5121-209", "#text": "Code de la santé publique - art. R5121-209 (T)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "TRANSFERE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590484", "@num": "R5121-210", "#text": "Code de la santé publique - art. R5121-210 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590513", "@num": "R5121-211", "#text": "Code de la santé publique - art. R5121-211 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590516", "@num": "R5121-212", "#text": "Code de la santé publique - art. R5121-212 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590490", "@num": "R5121-213", "#text": "Code de la santé publique - art. R5121-213 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590521", "@num": "R5121-214", "#text": "Code de la santé publique - art. R5121-214 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590524", "@num": "R5121-215", "#text": "Code de la santé publique - art. R5121-215 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590497", "@num": "R5121-216", "#text": "Code de la santé publique - art. R5121-216 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000026590222", "@num": "R5121-217", "#text": "Code de la santé publique - art. R5121-217 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" } ] }, "CONTEXTE": { "TEXTE": { "@cid": "JORFTEXT000026588856", "@nor": "AFSP1226229D", "@num": "2012-1236", "@nature": "DECRET", "TITRE_TXT": [ { "@fin": "2999-01-01", "#text": "Décret n° 2012-1236 du 6 novembre 2012 relatif aux médicaments de thérapie innovante", "@debut": "2999-01-01", "@id_txt": "JORFTEXT000026588856", "@c_titre_court": "Décret n°2012-1236 du 6 novembre 2012" }, { "@fin": "2999-01-01", "#text": "Décret n° 2012-1236 du 6 novembre 2012 relatif aux médicaments de thérapie innovante", "@debut": "2012-11-09", "@id_txt": "LEGITEXT000026589537", "@c_titre_court": "Décret n°2012-1236 du 6 novembre 2012" } ], "@ministere": "Ministère des affaires sociales et de la santé", "@date_publi": "2012-11-08", "@date_signature": "2012-11-06", "@num_parution_jo": "0260" } }, "VERSIONS": { "VERSION": [ { "LIEN_ART": { "@id": "LEGIARTI000026589556", "@fin": "2999-01-01", "@num": "3", "@debut": "2999-01-01", "@origine": "LEGI" } }, { "LIEN_ART": { "@id": "JORFARTI000026588877", "@fin": "2999-01-01", "@num": "3", "@debut": "2999-01-01", "@origine": "JORF" } } ] }, "BLOC_TEXTUEL": { "CONTENU": "
A modifié les dispositions suivantes :

- Code de la santé publique
Art. R5121-209, Art. R5121-217\n
\n

\n
\n
\n
\n
A modifié les dispositions suivantes :

- Code de la santé publique
Sct. Section 18 : Modalités d'application aux hôpitaux des armées et au centre de transfusion sanguine des armées., Sct. Section 17 : Conditions d'autorisation des médicaments de thérapie innovante préparés ponctuellement, Art. R5121-209\n
\n

\n
\n
A créé les dispositions suivantes :

- Code de la santé publique
\n Art. R5121-210, Art. R5121-211, Art. R5121-212, Art. R5121-213, Art. R5121-214, Art. R5121-215, Art. R5121-216\n
\n

\n
" } } }, "article_lien": [ { "article_id": "LEGIARTI000026589556", "cible": false, "cidtexte": "LEGITEXT000006072665", "id": "LEGIARTI000026592257", "typelien": "MODIFIE" } ], "follow": [ "LIENS.LIEN[@sens=cible,@typelien=CREATION].@id" ], "id": "LEGIARTI000026592257", "liens_entrants": true }

Article R5121-209 AUTONOME MODIFIE, en vigueur du 09/11/2012 au 19/02/2022 (Code de la santé publique)